Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares Acquired by Geode Capital Management LLC

Geode Capital Management LLC boosted its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 0.9% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,613,198 shares of the company’s stock after buying an additional 14,197 shares during the period. Geode Capital Management LLC owned approximately 1.74% of Acadia Healthcare worth $102,320,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the company. Blue Trust Inc. increased its stake in shares of Acadia Healthcare by 86.1% during the second quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after acquiring an additional 248 shares during the period. GAMMA Investing LLC boosted its holdings in Acadia Healthcare by 57.1% in the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after purchasing an additional 241 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in Acadia Healthcare during the 2nd quarter worth approximately $59,000. Covestor Ltd lifted its holdings in shares of Acadia Healthcare by 834.4% in the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company’s stock valued at $72,000 after buying an additional 1,018 shares during the period. Finally, DekaBank Deutsche Girozentrale purchased a new stake in shares of Acadia Healthcare in the third quarter valued at approximately $86,000.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the company. KeyCorp started coverage on Acadia Healthcare in a research report on Friday, October 11th. They issued a “sector weight” rating for the company. Cantor Fitzgerald reiterated a “neutral” rating and issued a $52.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, December 10th. StockNews.com lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Friday, November 22nd. Barclays reduced their price target on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research report on Friday, November 22nd. Finally, Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “hold” rating to a “buy” rating and raised their price objective for the company from $45.00 to $75.00 in a research note on Thursday, December 12th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, Acadia Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $75.44.

Acadia Healthcare Price Performance

Shares of NASDAQ:ACHC opened at $39.05 on Thursday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The business’s fifty day moving average price is $44.48 and its two-hundred day moving average price is $61.24. The stock has a market cap of $3.63 billion, a PE ratio of 12.80, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29. Acadia Healthcare Company, Inc. has a one year low of $36.50 and a one year high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. During the same quarter last year, the company earned $0.91 earnings per share. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. On average, analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.